Us Congress 2023-2024 Regular Session

Us Congress House Bill HR1285

Introduced
6/7/24  

Caption

Condemning the pro-abortion policies of the Biden administration.

Impact

The resolution indicates that recent changes, such as allowing pharmacies to dispense mifepristone without in-person visits, could lead to increased health risks for women and girls. Specifically, it contends that without necessary medical supervision, conditions like ectopic pregnancies could go undiagnosed, potentially leading to severe complications. Additionally, the resolution emphasizes that these policy adjustments could disproportionately affect women and girls in remote areas who may struggle to access emergency medical care when needed.

Summary

House Resolution 1285, introduced on June 7, 2024, addresses concerns surrounding the abortion drug mifepristone and denounces the pro-abortion policies of the Biden administration. The resolution outlines specific criticisms regarding the changes made by the Commissioner of Food and Drugs, which have allegedly reduced critical safety protocols for prescribing this medication. Notably, these modifications include the removal of the requirement for in-person dispensing by healthcare providers and easing access regulations, which supporters argue may compromise patient safety and wellbeing.

Contention

Supporters of the resolution claim that eliminating stringent safety measures enables reproductive coercion and endangers women's health. They point to cases where mifepristone has been misused, asserting that decreased oversight allows for instances where it could be exploited by abusers or traffickers. Conversely, opponents of the resolution likely advocate for broader access to abortion medications, stressing the importance of reproductive rights and autonomy, thus revealing a broader national debate regarding women's healthcare access and safety standards.

Companion Bills

No companion bills found.

Previously Filed As

US HR309

Expressing the sense of the House of Representatives that the Food and Drug Administration has the authority to approve drugs for abortion care.

US HB5806

Ending Chemical Abortions Act of 2023

US HB1525

Protecting Life from Chemical Abortions Act

US HR1304

Expressing support for the designation of June 19, 2024, as "World Sickle Cell Awareness Day" in order to increase public awareness across the United States and global community about sickle cell disease and the continued need for empirical research, early detection screenings, novel effective treatments leading to a cure, and preventative care programs with respect to complications from sickle cell anemia and conditions relating to sickle cell disease.

US HR522

Recognizing that Adriana Smith and her family's prolonged ordeal without their consent is the direct result of the Black maternal health crisis, the danger of laws that give rights to fetuses and take them away from pregnant people, and anti-abortion laws that continue to harm people who can become pregnant.

US HR1210

Condemning the Biden border crisis and the tremendous burdens law enforcement officers face as a result.

US HR1068

Condemning rape and sexual violence against women.

US HR1448

Expressing the sense of the House of Representatives that every person has the basic right to emergency health care, including abortion care.

US HR1021

Providing the sense of the House of Representatives that the political persecution of President Donald J. Trump is morally unjustifiable and has damaged institutional trust to an extraordinary degree; that the Biden administration's weaponization of the Federal Government against Donald Trump, the Republican Party's nominee for President in 2024, must end; that those responsible for the persecution of Donald Trump within the Biden administration must be held accountable by Congress; and that the United States would benefit enormously from having Donald J. Trump inaugurated once again as the President of the United States on January 20, 2025.

US HR957

Denouncing the Biden administration's open-borders policies, condemning the national security and public safety crisis along the southwest border, and urging President Biden to end his administration's open-borders policies.

Similar Bills

NH SB567

Directing the commissioner of the department of health and human services to compile a report on the availability of mifepristone and misoprostol.

CT SB01355

An Act Concerning Prescription Drugs, Devices And Nonlegend Drugs.

CA SB1428

Reproductive health: mifepristone and other medication.

CA AB54

Access to Safe Abortion Care Act.

US SR510

A resolution expressing the sense of the Senate that the scientific judgement of the Food and Drug Administration that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable and based on science.

NJ AR190

Urges United States Supreme Court to protect freedom of reproductive choice with respect to use of and access to mifepristone.

NJ SR78

Urges United States Supreme Court to protect freedom of reproductive choice with respect to use of and access to mifepristone.

CA AB260

Sexual and reproductive health care.